ReviewFrontiers in immunology2024

Identifying optimal tumor-associated antigen combinations with single-cell genomics to enable multi-targeting therapies.

Matthew A Nix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.